{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:03:34Z","timestamp":1789898614317,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T00:00:00Z","timestamp":1430179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T00:00:00Z","timestamp":1430179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/tpj.2015.25","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T10:08:48Z","timestamp":1430215728000},"page":"83-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["HLA-B*59:01: a marker for Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis caused by methazolamide in Han Chinese"],"prefix":"10.1038","volume":"16","author":[{"given":"F","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,28]]},"reference":[{"key":"BFtpj201525_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC . Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92\u201396.","journal-title":"Arch Dermatol"},{"key":"BFtpj201525_CR2","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau JC, Stern RS . Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272\u20131285.","journal-title":"N Engl J Med"},{"key":"BFtpj201525_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","volume":"49","author":"B Rzany","year":"1996","unstructured":"Rzany B, Mockenhaupt M, Baur S, Schroder W, Stocker U, Mueller J et al. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. J Clin Epidemiol 1996; 49: 769\u2013773.","journal-title":"J Clin Epidemiol"},{"key":"BFtpj201525_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2165\/00128071-200001060-00003","volume":"1","author":"PO Fritsch","year":"2000","unstructured":"Fritsch PO, Sidoroff A . Drug-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis. Am J Clin Dermatol 2000; 1: 349\u2013360.","journal-title":"Am J Clin Dermatol"},{"key":"BFtpj201525_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008; 128: 35\u201344.","journal-title":"J Invest Dermatol"},{"key":"BFtpj201525_CR6","first-page":"101","volume":"29","author":"RN Sud","year":"1981","unstructured":"Sud RN, Grewal SS . Stevens Johnson syndrome due to Diamox. Indian J Ophthalmol 1981; 29: 101\u2013103.","journal-title":"Indian J Ophthalmol"},{"key":"BFtpj201525_CR7","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(95)30810-X","volume":"102","author":"AJ Flach","year":"1995","unstructured":"Flach AJ, Smith RE, Fraunfelder FT . Stevens-Johnson syndrome associated with methazolamide treatment reported in two Japanese-American women. Ophthalmology 1995; 102: 1677\u20131680.","journal-title":"Ophthalmology"},{"key":"BFtpj201525_CR8","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1001\/archopht.1997.01100150552021","volume":"115","author":"S Shirato","year":"1997","unstructured":"Shirato S, Kagaya F, Suzuki Y, Joukou S . Stevens-Johnson syndrome induced by methazolamide treatment. Arch Ophthalmol 1997; 115: 550\u2013553.","journal-title":"Arch Ophthalmol"},{"key":"BFtpj201525_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/archopht.116.1.117","volume":"116","author":"JB Cotter","year":"1998","unstructured":"Cotter JB . Methazolamide-induced Stevens-Johnson syndrome: a warning!. Arch Ophthalmol 1998; 116: 117.","journal-title":"Arch Ophthalmol"},{"key":"BFtpj201525_CR10","first-page":"613","volume":"40","author":"YJ Park","year":"1999","unstructured":"Park YJ, Moon JI, Park CK . Three cases of Stevens-Johnson syndrome associated with methazolamide treatment. J Korean Ophthalmol Soc 1999; 40: 613\u2013618.","journal-title":"J Korean Ophthalmol Soc"},{"key":"BFtpj201525_CR11","first-page":"798","volume":"38","author":"EY Ahn","year":"2000","unstructured":"Ahn EY, Lee JB, Lee SC, Won YH . Four cases of Stevens\u2013Johnson syndrome associated with methazolamide treatment. Korean J Dermatol 2000; 38: 798\u2013801.","journal-title":"Korean J Dermatol"},{"key":"BFtpj201525_CR12","first-page":"2241","volume":"41","author":"JI Moon","year":"2000","unstructured":"Moon JI, Seo JH, Park CK . Association of HLA type with Stevens\u2013Johnson syndrome induced by methazolamide treatment. J Korean Ophthalmol Soc 2000; 41: 2241\u20132246.","journal-title":"J Korean Ophthalmol Soc"},{"key":"BFtpj201525_CR13","first-page":"561","volume":"43","author":"KH Sung","year":"2005","unstructured":"Sung KH, Jwong Y, Choi HU, Lee SK . Two cases of HLA-B59(+) Stevens\u2013Johnson syndrome (SJS)\u2013toxic epidermal necrolysis (TEN) associated with methazolamide treatment. Korean J Dermatol 2005; 43: 561\u2013563.","journal-title":"Korean J Dermatol"},{"key":"BFtpj201525_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2217\/pgs.10.54","volume":"11","author":"SH Kim","year":"2010","unstructured":"Kim SH, Kim M, Lee KW, Kim SH, Kang HR, Park HW et al. HLA-B*59:01 is strongly associated with methazolamide-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis. Pharmacogenomics 2010; 11: 879\u2013884.","journal-title":"Pharmacogenomics"},{"key":"BFtpj201525_CR15","first-page":"363","volume":"26","author":"RJ Jin","year":"2012","unstructured":"Jin RJ, Zhang XY, Jiang JX, Sun LP . One case of methazolamide-induced Stevens-Johnson syndrome [in Chinese]. Chin J Derm Venereol 2012; 26: 363\u2013364.","journal-title":"Chin J Derm Venereol"},{"key":"BFtpj201525_CR16","first-page":"179","volume":"9","author":"C Yan","year":"2012","unstructured":"Yan C, Xue HY, Cai CC . Stevens-Johnson syndrome induced by methazolamide tablet [in Chinese]. Chin J Drug Appl Monit 2012; 9: 179\u2013181.","journal-title":"Chin J Drug Appl Monit"},{"key":"BFtpj201525_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","volume":"209","author":"JC Roujeau","year":"2005","unstructured":"Roujeau JC . Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209: 123\u2013129.","journal-title":"Toxicology"},{"key":"BFtpj201525_CR18","volume-title":"The NCBI Handbook","author":"A Kitts","year":"2003","unstructured":"Kitts A, Feolo M, Helmberg W . The Major Histocompatibility Complex Database, dbMHC In: McEntyre J, Ostell J (eds) The NCBI Handbook. National Center for Biotechnology Information NIH: Bethesda, MD, USA, 2003."},{"key":"BFtpj201525_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","volume":"20","author":"JB Haldane","year":"1956","unstructured":"Haldane JB . The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956; 20: 309\u2013311.","journal-title":"Ann Hum Genet"},{"key":"BFtpj201525_CR20","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.4049\/jimmunol.165.6.3260","volume":"165","author":"K Maenaka","year":"2000","unstructured":"Maenaka K, Maenaka T, Tomiyama H, Takiguchi M, Stuart DI, Jones EY . Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes. J Immunol 2000; 165: 3260\u20133267.","journal-title":"J Immunol"},{"key":"BFtpj201525_CR21","first-page":"Unit 2.9","volume":"Chapter 2","author":"N Eswar","year":"2007","unstructured":"Eswar N, Webb B, Marti-Renom M, Madhusudhan M, Eramian D, Shen M et al. Comparative protein structure modeling using Modeller. Curr Protoc Protein Sci 2007; Chapter 2: Unit 2.9.","journal-title":"Curr Protoc Protein Sci"},{"key":"BFtpj201525_CR22","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009; 30: 2785\u20132791.","journal-title":"J Comput Chem"},{"key":"BFtpj201525_CR23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ . AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010; 31: 455\u2013461.","journal-title":"J Comput Chem"},{"key":"BFtpj201525_CR24","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML . Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983; 79: 926.","journal-title":"J Chem Phys"},{"key":"BFtpj201525_CR25","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L . Particle Mesh Ewald\u2014an N.Log(N) Method for Ewald Sums in Large Systems. J Chem Phys 1993; 98: 10089\u201310092.","journal-title":"J Chem Phys"},{"key":"BFtpj201525_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"JP Ryckaert","year":"1977","unstructured":"Ryckaert JP, Ciccotti G, Berendsen HJC . Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 1977; 23: 327\u2013341.","journal-title":"J Comput Phys"},{"key":"BFtpj201525_CR27","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/jcc.10349","volume":"24","author":"Y Duan","year":"2003","unstructured":"Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang W et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 2003; 24: 1999\u20132012.","journal-title":"J Comput Chem"},{"key":"BFtpj201525_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/wcms.1121","volume":"3","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, Case DA, Walker RC . An overview of the Amber biomolecular simulation package. Wiley Interdiscip Rev-Comput Mol Sci 2013; 3: 198\u2013210.","journal-title":"Wiley Interdiscip Rev-Comput Mol Sci"},{"key":"BFtpj201525_CR29","unstructured":"U.S. Food Drug Adm Information for Healthcare Professionals: Dangerous or Even Fatal Skin Reactions\u2014Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, and generics). U.S. Food Drug Adm.: Silver Spring, MD, USA, 2007."},{"key":"BFtpj201525_CR30","unstructured":"U.S. Food Drug Adm Information for Healthcare Professionals: Abacavir (marketed as Ziagen) and Abacavir-Containing Medications. U.S. Food Drug Adm.: Silver Spring, MD, USA, 2008."},{"key":"BFtpj201525_CR31","first-page":"248","volume":"41","author":"JH Ha","year":"2003","unstructured":"Ha JH, Song JY, Kim HO, Kim JW . A case of Stevens-Johnson syndrome caused by acetazolamide. Korean J Dermatol 2003; 41: 248\u2013250.","journal-title":"Korean J Dermatol"},{"key":"BFtpj201525_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1346-8138.2010.00921.x","volume":"38","author":"Y Her","year":"2011","unstructured":"Her Y, Kil MS, Park JH, Kim CW, Kim SS . Stevens-Johnson syndrome induced by acetazolamide. J Dermatol 2011; 38: 272\u2013275.","journal-title":"J Dermatol"},{"key":"BFtpj201525_CR33","doi-asserted-by":"publisher","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","volume":"39","author":"FF Gonzalez-Galarza","year":"2011","unstructured":"Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR . Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011; 39: D913\u2013D919.","journal-title":"Nucleic Acids Res"},{"key":"BFtpj201525_CR34","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/ng.478","volume":"41","author":"CJ Ross","year":"2009","unstructured":"Ross CJ, Katzov-Eckert H, Dube MP, Brooks B, Rassekh SR, Barhdadi A et al. Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nat Genet 2009; 41: 1345\u20131349.","journal-title":"Nat Genet"},{"key":"BFtpj201525_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/tpj.2008.4","volume":"9","author":"MR Nelson","year":"2009","unstructured":"Nelson MR, Bacanu SA, Mosteller M, Li L, Bowman CE, Roses AD et al. Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions. Pharmacogenomics J 2009; 9: 23\u201333.","journal-title":"Pharmacogenomics J"},{"key":"BFtpj201525_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrg2751","volume":"11","author":"AK Daly","year":"2010","unstructured":"Daly AK . Genome-wide association studies in pharmacogenomics. Nat Rev Genet 2010; 11: 241\u2013246.","journal-title":"Nat Rev Genet"},{"key":"BFtpj201525_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428: 486.","journal-title":"Nature"},{"key":"BFtpj201525_CR38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1124\/pr.113.007450","volume":"65","author":"J Uetrecht","year":"2013","unstructured":"Uetrecht J, Naisbitt DJ . Idiosyncratic adverse drug reactions: current concepts. Pharmacol Rev 2013; 65: 779\u2013808.","journal-title":"Pharmacol Rev"},{"key":"BFtpj201525_CR39","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.4049\/jimmunol.1302306","volume":"192","author":"J Yun","year":"2014","unstructured":"Yun J, Marcaida MJ, Eriksson KK, Jamin H, Fontana S, Pichler WJ et al. Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01. J Immunol 2014; 192: 2984\u20132993.","journal-title":"J Immunol"},{"key":"BFtpj201525_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nature11147","volume":"486","author":"PT Illing","year":"2012","unstructured":"Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M et al. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 2012; 486: 554\u2013558.","journal-title":"Nature"},{"key":"BFtpj201525_CR41","doi-asserted-by":"publisher","first-page":"9959","DOI":"10.1073\/pnas.1207934109","volume":"109","author":"DA Ostrov","year":"2012","unstructured":"Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S et al. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci USA 2012; 109: 9959\u20139964.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtpj201525_CR42","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","volume":"129","author":"CY Wei","year":"2012","unstructured":"Wei CY, Chung WH, Huang HW, Chen YT, Hung SI . Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. J Allergy Clin Immunol 2012; 129: 1562\u20131569.","journal-title":"J Allergy Clin Immunol"},{"key":"BFtpj201525_CR43","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","volume":"28","author":"D Chessman","year":"2008","unstructured":"Chessman D, Kostenko L, Lethborg T, Purcell AW, Williamson NA, Chen Z et al. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 2008; 28: 822\u2013832.","journal-title":"Immunity"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj201525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201525","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T17:03:01Z","timestamp":1717866181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj201525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,28]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFtpj201525"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2015.25","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,28]]},"assertion":[{"value":"14 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}